Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia
Archivos de Bronconeumología · 2023-02 · 59 (2) · 90-100
DOI: 10.1016/j.arbres.2022.09.005 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Archivos de Bronconeumología, 2023-02. Verfasst von Sergi Pascual-Guardia und 17 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Department, Hospital del Mar-IMIM, CEXS, UPF, CIBERES, BRN, Barcelona, Spain; Division of Pulmonary Diseases & Critical Care Medicine, Un…. Hauptthemen laut MEDLINE: Pneumonia, Pulmonary Disease, Chronic Obstructive, Community-Acquired Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is strongly associated with the development of community-acquired pneumonia (CAP). Limited data are available on risk factors for difficult to manage bacteria such as Pseudomonas aeruginosa in COPD patients with CAP. Our objective was to assess the microbiological patterns associated with risk factors that determine empiric antibiotic therapy in hospitalized COPD patients with CAP. METHODS: We performed a secondary data analysis of an international, multicenter, observational, point-prevalence study involving hospitalized COPD patients with CAP from March to June 2015. After identifying the risk factors associated with different microorganisms, we developed a scoring system to guide decision-making about empiric anti-pseudomonal antibiotic therapy in this population. RESULTS: We enrolled 689 hospitalized COPD patients with CAP with documented microbiological testing. The most frequent microorganisms isolated were Streptococcus pneumoniae (8%) and Gram-negative bacteria (8%), P. aeruginosa (7%) and Haemophilus influenzae (3%). We developed a scoring system incorporating the variables independently associated with P. aeruginosa that include a previous P. aeruginosa isolation or infection (OR 14.2 [95%CI 5.7-35.2]), hospitalization in the past 12 months (OR 3.7 [1.5-9.2]), and bronchiectasis (OR 3.2 [1.4-7.2]). Empiric anti-pseudomonal antibiotics were overutilized in COPD patients with CAP. The new scoring system has the potential to reduce empiric anti-pseudomonal antibiotic use from 54.1% to 6.2%. CONCLUSIONS: COPD patients with CAP present different microbiological profiles associated with unique risk factors. Anti-pseudomonal treatment is a critical decision when selecting empiric antibiotic therapy. We developed a COPD scoring system to guide decision-making about empiric anti-pseudomonal antibiotic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Respiratory Department, Hospital del Mar-IMIM, CEXS, UPF, CIBERES, BRN, Barcelona, Spain; Division of Pulmonary Diseases & Critical Care Medicine, University of Texas Health San Antonio, San Antonio, TX,USA.
- Division of Pulmonary Diseases & Critical Care Medicine, University of Texas Health San Antonio, San Antonio, TX,USA; Department of Biomedical Sciences, Humanitas University, IRCCS Humanitas Research Hospital, Respirato…
- Division of Pulmonary Diseases & Critical Care Medicine, University of Texas Health San Antonio, San Antonio, TX,USA; Critical Care Department, Hospital del Mar-IMIM, Critical Illness Research Group (GREPAC), Barcelona,…
- Department of Biomedical Sciences, Humanitas University, IRCCS Humanitas Research Hospital, Respiratory Unit, Milan, Italy.
- Respiratory Department, Hospital del Mar-IMIM, CEXS, UPF, CIBERES, BRN, Barcelona, Spain.
- Division of Pulmonary Diseases & Critical Care Medicine, University of Texas Health San Antonio, San Antonio, TX,USA; Section of Pulmonary & Critical Care Medicine, South Texas Veterans Health Care System,USA.
Zitieren
APA
Pascual-Guardia, S., Amati, F., Marin-Corral, J., Aliberti, S., Gea, J., Soni, N. J., Rodriguez, A., Sibila, O., Sanz, F., Sotgiu, G., Marcos, P. J., Uranga, A., Milenkovic, B., Meyer, C. N., Kolditz, M., Anzueto, A. R., Restrepo, M. I., & GLIMP investigators (2023). Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia. Archivos de Bronconeumología, 59(2), 90-100. https://doi.org/10.1016/j.arbres.2022.09.005
Vancouver
Pascual-Guardia S, Amati F, Marin-Corral J, Aliberti S, Gea J, Soni NJ, et al. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia. Archivos de Bronconeumología. 2023;59(2):90-100. doi:10.1016/j.arbres.2022.09.005
BibTeX
@article{PascualGuardia2023,
author = {Pascual-Guardia, Sergi and Amati, Francesco and Marin-Corral, Judith and Aliberti, Stefano and Gea, Joaquim and Soni, Nilam J and Rodriguez, Alejandro and Sibila, Oriol and Sanz, Francisco and Sotgiu, Giovanni and Marcos, Pedro J and Uranga, Ane and Milenkovic, Branislava and Meyer, Christian N and Kolditz, Martin and Anzueto, Antonio R and Restrepo, Marcos I and GLIMP investigators, GLIMP investigators},
title = {Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia},
journal = {Archivos de Bronconeumología},
year = {2023},
volume = {59},
number = {2},
pages = {90--100},
doi = {10.1016/j.arbres.2022.09.005}
}
EUVIMED